Abstract
A NEW APPROACH TO MAXIMISE THE VALUE OF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Full text
M.J. Taylor, P. Conway, M. LebmeierYork Health Economics Consortium, University of York, York; Market Access and Reimbursement, Wyeth Europa, Maidenhead; Strategic Planning, Wyeth Pharmaceuticals, Taplow, United KingdomCitation: Ann Rheum Dis, volume 67, supplement II, year 2008, page 607Session: RA – Anti-TNF therapy
6 organizations
Organization
York Health Economics ConsortiumOrganization
University of YorkOrganization
Market Access and ReimbursementOrganization
Wyeth EuropaOrganization
Strategic PlanningOrganization
Wyeth Pharmaceuticals